Feasibility of using limited-population-based arterial input function for pharmacokinetic modeling of osteosarcoma dynamic contrast-enhanced MRI data
about
Parameterizing the Logistic Model of Tumor Growth by DW-MRI and DCE-MRI Data to Predict Treatment Response and Changes in Breast Cancer Cellularity during Neoadjuvant Chemotherapy.Feasibility of using limited-population-based average R10 for pharmacokinetic modeling of osteosarcoma dynamic contrast-enhanced magnetic resonance imaging data.Average arterial input function for quantitative dynamic contrast enhanced magnetic resonance imaging of neck nodal metastases.Temporal sampling requirements for reference region modeling of DCE-MRI data in human breast cancerDynamic Contrast-enhanced MRI in Renal Tumors: Common Subtype Differentiation using PharmacokineticsThe MRI-measured arterial input function resulting from a bolus injection of Gd-DTPA in a rat model of stroke slightly underestimates that of Gd-[14C]DTPA and marginally overestimates the blood-to-brain influx rate constant determined by Patlak plotModel-based blind estimation of kinetic parameters in dynamic contrast enhanced (DCE)-MRI.Current and future trends in magnetic resonance imaging assessments of the response of breast tumors to neoadjuvant chemotherapy.Quantitative analysis of 3-Tesla magnetic resonance imaging in the differential diagnosis of breast lesionsA novel AIF tracking method and comparison of DCE-MRI parameters using individual and population-based AIFs in human breast cancer.Discrimination of benign and malignant breast lesions by using shutter-speed dynamic contrast-enhanced MR imaging.Demonstration of the reproducibility of free-breathing diffusion-weighted MRI and dynamic contrast enhanced MRI in children with solid tumours: a pilot studyCorrelation of volume transfer coefficient Ktrans with histopathologic grades of gliomasReproducibility of Dynamic Contrast-Enhanced MRI in Renal Cell Carcinoma: A Prospective Analysis on Intra- and Interobserver and Scan-Rescan Performance of Pharmacokinetic Parameters.Tumor Vascularity in Renal Masses: Correlation of Arterial Spin-Labeled and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Assessments.Assessment of renal function with dynamic contrast-enhanced MR imagingAssessment of repeatability and treatment response in early phase clinical trials using DCE-MRI: comparison of parametric analysis using MR- and CT-derived arterial input functions.Dynamic Contrast-enhanced MR Imaging in Renal Cell Carcinoma: Reproducibility of Histogram Analysis on Pharmacokinetic Parameters.DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: pilot study findings.Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival.Use of cardiac output to improve measurement of input function in quantitative dynamic contrast-enhanced MRIFunctional MRI of the kidneys.Tracer-kinetic modeling of dynamic contrast-enhanced MRI and CT: a primer.Assessment of pharmacokinetics for microvessel proliferation by DCE-MRI for early detection of physeal bone bridge formation in an animal model.Assessment of DCE-MRI parameters for brain tumors through implementation of physiologically-based pharmacokinetic model approaches for Gd-DOTA.Distribution of Intravascular and Extravascular Extracellular Volume Fractions by Total Area under Curve for Neovascularization Assessment by Dynamic Contrast-Enhanced Magnetic Resonance Imaging.Pharmacokinetic analysis based on dynamic contrast-enhanced MRI for evaluating tumor response to preoperative therapy for oral cancer.Active Crohn's disease in the small bowel: evaluation by diffusion weighted imaging and quantitative dynamic contrast enhanced MR imaging.Baseline assessment and comparison of arterial anatomy, hyperemic flow, and skeletal muscle perfusion in peripheral artery disease: The Cardiovascular Cell Therapy Research Network "Patients with Intermittent Claudication Injected with ALDH Bright CRetrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China.Distinguishing benign and malignant breast tumors: preliminary comparison of kinetic modeling approaches using multi-institutional dynamic contrast-enhanced MRI data from the International Breast MR Consortium 6883 trial.Extended graphical model for analysis of dynamic contrast-enhanced MRI.Triple-phase contrast-enhanced MRI for the prediction of preoperative chemotherapeutic effect in patients with osteosarcoma: comparison with (99m)Tc-MIBI scintigraphy.Automatic individual arterial input functions calculated from PCA outperform manual and population-averaged approaches for the pharmacokinetic modeling of DCE-MR images.
P2860
Q30639288-C608A7AF-5EBC-4988-8594-C10AD8E0515BQ33417505-8E2F8251-4CF6-48C4-9FA2-9B72B063D620Q33422150-1D14A572-314F-49B8-9D24-791619D97034Q33474971-4CFA8361-238F-4FFA-B668-3BE68EB01B72Q33780388-F6CEDAC3-ED76-4546-8288-17FAF95164A0Q33890243-33C0D0EE-A8E7-4543-9856-DB403D55F0C3Q33908053-7D5E0F92-7995-420D-B3E5-8BA7DE2B20EEQ34189855-21EA23C4-9ED0-4773-81EF-A104A04E709EQ35048378-EB801CF8-93C3-4DBF-910D-B9019FE7AE81Q35223101-AFD8CE87-627C-45B4-8295-FB4EB18E4462Q35407336-9DE53A27-8944-4678-AB33-2705A7132AB9Q35929346-70AD193E-2C08-46D9-9DA1-F417EF8AC9EBQ36103551-DA4613B3-4839-472F-88CE-188A69CBD7E7Q36256130-BE7372F1-3C54-43EA-ACD0-4DEF8C7A76E9Q36421776-209D6C59-65C3-4065-8E4E-56E56D247386Q36990684-E458DF68-6FD7-4190-9EEE-D25244060401Q36994280-3886D0E7-893B-44EB-B3F8-75015E8FA172Q37067622-2EC3EE82-88FA-489E-8663-235692D1A97DQ37093041-B2B4DE17-302C-4264-B7F5-784D4C3E0FA8Q37316228-BC2DFB5A-2667-48E3-8ACC-B3AC8ECB5F9DQ37416974-0D5C5BB6-6706-4574-B960-9BEC0C942312Q38077165-BAED26B6-7DED-4E50-80A5-66293DD166C6Q38096874-B60B3725-467C-4BE2-9D10-881010C6A915Q38865642-B51AC295-8953-4BF6-933F-8A72AD410650Q39372575-B21B2556-C532-48AA-BD29-5313F77AC08CQ42931964-0D7D8828-4ADA-413E-A5AF-9F75F0517B7CQ45912968-6CD9A947-C7B1-4043-81A7-063674B40076Q46316353-B31A0551-F60D-4BE8-BA31-C97D2BDB067FQ47148707-98BC155B-A542-4850-AE7D-84BD1B50A937Q47549197-697338D4-63B4-49D6-9CF0-9DBAA19D9B84Q48119380-32BB7995-9FFA-4BEA-A275-9CF22C4BDAE2Q51593516-9E0A1531-F9D1-44DA-95E1-1A5754A6F26DQ53183263-C346DE2F-49FA-4A5B-8C88-B3422DFC9130Q53388852-37C89290-2460-4F8B-8DB5-DB332E3A78F9
P2860
Feasibility of using limited-population-based arterial input function for pharmacokinetic modeling of osteosarcoma dynamic contrast-enhanced MRI data
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Feasibility of using limited-p ...... mic contrast-enhanced MRI data
@ast
Feasibility of using limited-p ...... mic contrast-enhanced MRI data
@en
type
label
Feasibility of using limited-p ...... mic contrast-enhanced MRI data
@ast
Feasibility of using limited-p ...... mic contrast-enhanced MRI data
@en
prefLabel
Feasibility of using limited-p ...... mic contrast-enhanced MRI data
@ast
Feasibility of using limited-p ...... mic contrast-enhanced MRI data
@en
P2093
P2860
P356
P1476
Feasibility of using limited-p ...... mic contrast-enhanced MRI data
@en
P2093
Jason A Koutcher
Lawrence H Schwartz
P2860
P304
P356
10.1002/MRM.21432
P577
2008-05-01T00:00:00Z